Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tartaric acid

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Tartaric acid?

Tartaric acid is an investigational drug.

There have been 9 clinical trials for Tartaric acid. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2019.

The most common disease conditions in clinical trials are Lymphoma, Mantle-Cell, Lymphoma, B-Cell, and Venous Thromboembolism. The leading clinical trial sponsors are Boehringer Ingelheim, Population Health Research Institute, and Shiraz University of Medical Sciences.

Recent Clinical Trials for Tartaric acid
A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy VolunteersPopulation Health Research InstitutePhase 4
This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are ToleratedBoehringer IngelheimPhase 1
The Effects of Rhus Coriaria L. on Serum Uric Acid LevelsShiraz University of Medical SciencesN/A

See all Tartaric acid clinical trials

Clinical Trial Summary for Tartaric acid

Top disease conditions for Tartaric acid
Top clinical trial sponsors for Tartaric acid

See all Tartaric acid clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.